TNFRSF11B and neoplasm: CD3+CD4+ T cells from 4T1 tumors expressed minimal levels of Tnfrsf11b, further emphasizing the differential immune programming induced by metastatic versus nonmetastatic tumor microenvironments (Fig. 7A).